SCHEMBL134488

SCHEMBL134488

O=C=NC1CC1c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 10/20 0.43
MAOA P21397 7/20 0.43
HTR2C P28335 7/20 0.43
KDM1A O60341 5/20 0.43
CYP2C19 P33261 4/20 0.43
CYP2B6 P20813 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
LMNA P02545 2/20 0.43
TAAR1 Q96RJ0 2/20 0.43
CYP3A4 P08684 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
CYP2A6 P11509 1/20 0.43
SLC6A2 P23975 1/20 0.43
ADRA1A P35348 1/20 0.43
DRD3 P35462 1/20 0.43
SLC6A3 Q01959 1/20 0.43
KCNH2 Q12809 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL660964 1.00 MAOB (0.43) MAOBMAOAHTR2CKDM1ACYP2C19
SCHEMBL5016297 1.00 MAOB (0.43) MAOBMAOAHTR2CKDM1ACYP2C19
SCHEMBL1870104 1.00 MAOB (0.43) MAOBMAOAHTR2CKDM1ACYP2C19
SCHEMBL2160352 1.00 MAOB (0.43) MAOBMAOAHTR2CKDM1ACYP2C19
SCHEMBL12143680 1.00 MAOB (0.43) MAOBMAOAHTR2CKDM1ACYP2C19
SCHEMBL7731515 0.90 MAOB (0.36) MAOBMAOAHTR2CKDM1ACYP2C19
SCHEMBL7731519 0.90 MAOB (0.36) MAOBMAOAHTR2CKDM1ACYP2C19
SCHEMBL10527956 0.81 FFAR1 (0.41) HTR2CCYP2C19CYP1A2CYP2C9CYP3A4
SCHEMBL10529544 0.81 SLC9A1 (0.41) HTR2CSLC6A2SLC6A3SLC9A1HTR2B
SCHEMBL10529540 0.81 SLC9A1 (0.41) HTR2CSLC6A2SLC6A3SLC9A1HTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 490 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151136-A1 CATALYST COMPOSITION FOR POLYURETHANES MOMENTIVE PERFORMANCE MATERIALS INC. 2023-05-18 US claimed
US-20230134280-A1 CATALYSTS FOR THE FORMATION OF POLYURETHANES MOMENTIVE PERFORMANCE MATERIALS INC. 2023-05-04 US claimed
EP-4114566-A1 CATALYST COMPOSITION FOR POLYURETHANES Momentive Performance Materials Inc. (US) 2023-01-11 EP claimed
EP-4114877-A1 CATALYSTS FOR THE FORMATION OF POLYURETHANES Momentive Performance Materials Inc. (US) 2023-01-11 EP claimed
CN-115243789-A Catalyst composition for polyurethane 迈图高新材料公司 2022-10-25 CN claimed
CN-115210283-A Catalysts for polyurethane formation 迈图高新材料公司 2022-10-18 CN claimed
US-20210332211-A1 CATALYSTS FOR PRODUCING POLYURETHANES MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) 2021-10-28 US claimed
EP-3612581-B1 CATALYSTS FOR PRODUCING POLYURETHANES MOMENTIVE PERFORMANCE MAT GMBH (DE) 2020-12-23 EP claimed
CN-110891994-A Catalyst for producing polyurethane 莫门蒂夫性能材料有限公司 2020-03-17 CN claimed
EP-3612581-A1 CATALYSTS FOR PRODUCING POLYURETHANES Momentive Performance Materials GmbH (DE) 2020-02-26 EP claimed
US-20050272902-A1 Colorant compositions XEROX CORPORATION 2005-12-08 US claimed
US-20040215002-A1 Colorant compositions XEROX CORPORATION 2004-10-28 US claimed
US-20040215038-A1 Colorant precursor compositions XEROX CORPORATION 2004-10-28 US claimed
US-20040214918-A1 Colorant compositions XEROX CORPORATION 2004-10-28 US claimed
US-20040215022-A1 Colorant compositions XEROX CORPORATION 2004-10-28 US claimed
US-6790267-B1 METHINE COLORANT COMPOUNDS FOR PHASE CHANGE INKS XEROX CORPORATION 2004-09-14 US claimed
US-20040167249-A1 Phase change inks with isocyanate-derived antioxidants and UV stabilizers XEROX CORPORATION 2004-08-26 US claimed
US-6764541-B1 Colorant compositions XEROX CORPORATION 2004-07-20 US claimed
US-6652635-B2 Cyan phase change inks XEROX CORPORATION 2003-11-25 US claimed
US-20030079645-A1 Cyan phase change inks XEROX CORPORATION 2003-05-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040215022-A1 Colorant compositions ARSA, TST, IK MAOB 1344/4885MAOA 1469/4885HTR2C 2136/4885
US-20040215038-A1 Colorant precursor compositions RB1, SULT1A1, CBR1 MAOB 1214/4885MAOA 776/4885HTR2C 1864/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.